Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 6,622 clinical trials worldwide
Search
Showing 1-50 of 6,622 trials
Active filters:
Phase: Phase 3
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (6,622)
NCT07075315
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
PHASE3
Not yet recruiting
100 participants
Started: Jan 31, 2028 · Completed: Dec 31, 2031
1 condition
2 sponsors
3 locations
NCT05951205
Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/βC Genotype
PHASE3
Not yet recruiting
12 participants
Started: Jul 31, 2027 · Completed: Dec 31, 2033
1 condition
1 sponsor
0 locations
NCT02864888
Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
PHASE3
Not yet recruiting
30 participants
Started: Jun 30, 2027 · Completed: Dec 31, 2029
1 condition
1 sponsor
0 locations
NCT06566183
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
PHASE3
Not yet recruiting
1,200 participants
Started: Dec 31, 2026 · Completed: Dec 31, 2032
3 conditions
1 sponsor
6 locations
NCT06966856
This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week
PHASE3
Not yet recruiting
23 participants
Started: Dec 30, 2026 · Completed: Dec 30, 2029
1 condition
1 sponsor
0 locations
NCT06136507
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
PHASE3
Not yet recruiting
76 participants
Started: Dec 25, 2026 · Completed: Dec 31, 2026
1 condition
1 sponsor
13 locations
NCT06546735
Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO)
PHASE3
Not yet recruiting
816 participants
Started: Nov 30, 2026 · Completed: Aug 30, 2028
1 condition
1 sponsor
1 location
NCT06608472
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
PHASE3
Not yet recruiting
292 participants
Started: Nov 30, 2026 · Completed: Oct 30, 2029
1 condition
1 sponsor
1 location
NCT06560333
iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)
PHASE3
Not yet recruiting
612 participants
Started: Nov 30, 2026 · Completed: Feb 28, 2029
1 condition
1 sponsor
1 location
NCT06234345
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
PHASE3
Not yet recruiting
1,252 participants
Started: Sep 30, 2026 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT07057479
Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin
PHASE3
Not yet recruiting
408 participants
Started: Sep 30, 2026 · Completed: Feb 29, 2028
1 condition
1 sponsor
1 location
NCT07129759
Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency
PHASE3
Not yet recruiting
150 participants
Started: Sep 30, 2026 · Completed: Feb 28, 2030
1 condition
1 sponsor
0 locations
NCT07174414
Cilostazol for Prevention of Recurrent Stroke Trial
PHASE3
Not yet recruiting
2,000 participants
Started: Aug 31, 2026 · Completed: Jul 31, 2031
7 conditions
5 sponsors
1 location
NCT06987383
Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity
PHASE3
Not yet recruiting
40 participants
Started: Aug 31, 2026 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT07211802
CKM For Safe Use of SGLT2i in Type 1 Diabetes
PHASE3
Not yet recruiting
52 participants
Started: Jul 1, 2026 · Completed: Dec 31, 2030
1 condition
5 sponsors
1 location
NCT07177872
A Long-term Efficacy and Safety of NTQ5082 Capsules
PHASE3
Not yet recruiting
78 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT07162896
Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis
PHASE3
Not yet recruiting
66 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05735431
Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil
PHASE3
Not yet recruiting
132 participants
Started: Jun 30, 2026 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05564169
Masitinib in Patients With Mild Alzheimer's Disease
PHASE3
Not yet recruiting
600 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2029
1 condition
1 sponsor
9 locations
NCT05959421
Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure
PHASE3
Not yet recruiting
70 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2028
1 condition
5 sponsors
2 locations
NCT07061977
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
PHASE3
Recruiting
336 participants
Started: Jun 26, 2026 · Completed: Dec 31, 2030
8 conditions
1 sponsor
6 locations
NCT07158567
Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT
PHASE3
Not yet recruiting
213 participants
Started: Jun 1, 2026 · Completed: Dec 31, 2031
2 conditions
1 sponsor
2 locations
NCT07210008
"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"
PHASE3
Not yet recruiting
120 participants
Started: Jun 1, 2026 · Completed: Dec 1, 2028
1 condition
1 sponsor
0 locations
NCT04457076
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
PHASE3
Not yet recruiting
1,525 participants
Started: Jun 1, 2026 · Completed: Jun 1, 2032
2 conditions
2 sponsors
27 locations
NCT07220187
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
PHASE3
Not yet recruiting
102 participants
Started: May 2, 2026 · Completed: Oct 31, 2036
3 conditions
2 sponsors
0 locations
NCT06315920
Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department
PHASE3
Not yet recruiting
226 participants
Started: May 1, 2026 · Completed: Jul 1, 2028
1 condition
2 sponsors
0 locations
NCT07021937
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
PHASE3
Not yet recruiting
120 participants
Started: May 1, 2026 · Completed: Apr 30, 2031
1 condition
3 sponsors
1 location
NCT07212998
Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial
PHASE3
Not yet recruiting
750 participants
Started: Apr 30, 2026 · Completed: May 31, 2030
2 conditions
2 sponsors
1 location
NCT05209984
A Phase 3, Double-blind/double-dummy, Safety/efficacy/superiority of Sibutramine/topiramate XR in Adults with Overweight
PHASE3
Not yet recruiting
1,855 participants
Started: Apr 30, 2026 · Completed: Mar 31, 2028
2 conditions
1 sponsor
2 locations
NCT06715462
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
PHASE3
Not yet recruiting
666 participants
Started: Apr 30, 2026 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
NCT05497401
A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS
PHASE3
Not yet recruiting
300 participants
Started: Apr 30, 2026 · Completed: Oct 31, 2028
1 condition
1 sponsor
0 locations
NCT06381661
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Bayesian Basket Trial
PHASE3
Not yet recruiting
2,000 participants
Started: Apr 1, 2026 · Completed: Apr 1, 2032
1 condition
1 sponsor
0 locations
NCT07090343
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
PHASE3
Not yet recruiting
826 participants
Started: Apr 1, 2026 · Completed: Apr 1, 2031
2 conditions
1 sponsor
0 locations
NCT06579755
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
PHASE3
Not yet recruiting
800 participants
Started: Apr 1, 2026 · Completed: Apr 14, 2027
1 condition
1 sponsor
0 locations
NCT07108582
Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery
PHASE3
Not yet recruiting
270 participants
Started: Apr 1, 2026 · Completed: Jul 1, 2028
1 condition
1 sponsor
0 locations
NCT07159373
Better Options for Lymphatic Filariasis Treatment
PHASE3
Not yet recruiting
5,100 participants
Started: Mar 31, 2026 · Completed: Jun 30, 2028
3 conditions
3 sponsors
1 location
NCT05637710
Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil
PHASE3
Not yet recruiting
754 participants
Started: Mar 31, 2026 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT06956014
Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Low Back Pain
PHASE3
Not yet recruiting
700 participants
Started: Mar 31, 2026 · Completed: Sep 30, 2027
1 condition
1 sponsor
0 locations
NCT06905210
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
PHASE3
Not yet recruiting
526 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2027
2 conditions
1 sponsor
1 location
NCT07030101
A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
PHASE3
Not yet recruiting
282 participants
Started: Mar 31, 2026 · Completed: Sep 30, 2029
1 condition
1 sponsor
0 locations
NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
PHASE3
Not yet recruiting
100 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2031
1 condition
1 sponsor
0 locations
NCT05809908
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
PHASE3
Not yet recruiting
535 participants
Started: Mar 31, 2026 · Completed: Jan 31, 2029
1 condition
1 sponsor
0 locations
NCT07210515
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
PHASE3
Not yet recruiting
270 participants
Started: Mar 31, 2026 · Completed: Jan 31, 2028
1 condition
1 sponsor
0 locations
NCT03176186
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
PHASE3
Not yet recruiting
1,436 participants
Started: Mar 31, 2026 · Completed: May 31, 2030
1 condition
1 sponsor
10 locations
NCT07054099
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
PHASE3
Not yet recruiting
474 participants
Started: Mar 31, 2026 · Completed: Jul 31, 2036
2 conditions
1 sponsor
0 locations
NCT07184385
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
PHASE3
Not yet recruiting
60 participants
Started: Mar 31, 2026 · Completed: Sep 30, 2027
4 conditions
1 sponsor
0 locations
NCT07167940
Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
PHASE3
Not yet recruiting
90 participants
Started: Mar 9, 2026 · Completed: Feb 2, 2030
1 condition
1 sponsor
2 locations
NCT07160686
Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment
PHASE3
Not yet recruiting
1,456 participants
Started: Mar 2, 2026 · Completed: Mar 30, 2030
1 condition
1 sponsor
1 location
NCT07055295
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
PHASE3
Not yet recruiting
390 participants
Started: Mar 1, 2026 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04637282
Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3
PHASE3
Not yet recruiting
39 participants
Started: Mar 1, 2026 · Completed: Mar 31, 2026
1 condition
1 sponsor
0 locations
«
Previous
1
2
2
3
4
More pages
133
Next